CannabisNewsBreaks Archive - CannabisNewsWire

FridayJun 09, 2023 10:42 am

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Portfolio of Worldwide Patents

Lexaria Bioscience Corp. (NASDAQ: LEXX), the global leader in enhancing the speed and efficiency of orally delivered fat-soluble active molecules and drugs through its patented DehydraTECH(TM) technology, recently announced it had received notification of four newly awarded or allowed patents. “The new patents will add to Lexaria’s growing portfolio and, upon award, will bring the total number of patents granted worldwide to 32, with several more pending,” a recent article reads. “Lexaria’s new patent in Japan is under Patent Family #3: Stable Ready-to-Drink Beverage Compositions Comprising Lipophilic Agents. This patent is the fifth awarded in Japan, strengthening the company’s growing…

TuesdayJun 06, 2023 2:54 pm

CannabisNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Receives Notice of Allowance for Patent on IGC-501

IGC Pharma (NYSE American: IGC) today announced its receipt of a Notice of Allowance from the Commissioner of Patents, Canada, for its patent filing on the use of cannabinoids in the treatment of seizures (“IGC-501”). The formulation additionally received an intent to grant from the European Patent Office. With these and a previous award, the formulation for treating seizures is protected in the U.S., Canada and certain European countries. IGC provided animal data (dogs) on the reduction in the number of seizures by using a combination of cannabidiol (“CBD”) and phenobarbital versus either alone. The company intends to pursue the…

MondayJun 05, 2023 12:48 pm

CannabisNewsBreaks – IGC Pharma Inc.’s (NYSE American: IGC) Advisor and Inventor of TGR-63 Receives National Technology Award

IGC Pharma (NYSE American: IGC) today announced recognition of its advisor, Professor T. Govindaraju, the inventor of the investigational Alzheimer’s drug candidate, TGR-63. According to the announcement, Govindaraju received the Government of India-instituted National Technology Award (Translational Research) for “Outstanding Contribution in Commercializing Innovative Indigenous Technologies” from the Minister of State for Science and Technology and Earth Sciences. The Department of Science and Technology (“DST”)-Technology Development Board (“TDB”), Government of India presented Professor Govindaraju with the prestigious award on May 14, 2023. The awards acknowledge excellence and success in the commercialization of technology indigenous to India, and Professor Govindaraju is…

ThursdayJun 01, 2023 12:14 pm

CannabisNewsBreaks – ECGI Holdings Inc. (ECGI) Closes Acquisition of East West Pharma Group

ECGI Holdings (OTC: ECGI), D/B/A Elite Cannabis Group Incorporated, is a Nevada-based portfolio company pivoting into the legal cannabis and cannabinoid marketplace. The company today announced the closing of its acquisition of East West Pharma Group, Inc. ("EWPG"), a Wyoming corporation with specialized equipment and experienced personnel, including leaders in the cannabinoid extraction and product manufacturing space. “We couldn’t be more excited to have this deal closed and in the books as we look ahead to an exciting summer,” said ECGI CEO Danny Wong . “The cannabis market has been recovering, with spot prices up over 20% in the past…

ThursdayJun 01, 2023 11:41 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Sponsored Research Presented at Canadian Neuroscience Meeting

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids, today announced that results from a neurodegenerative disease study were presented in a scientific poster at the Canadian Neuroscience Meeting in Montreal from May 28-31, 2023. The InMed sponsored research demonstrated the ability of a specific rare cannabinoid (“pCBx”) in InMed’s 900 Series library of potential candidates that reduces amyloid toxicity and tau protein expression while enhancing neuronal cell growth and neuritogenesis markers in vitro. These are all considered to be important targets in the potential treatment of neurodegenerative diseases such as Alzheimer’s.…

FridayMay 26, 2023 11:54 am

CannabisNewsBreaks – Bright Green Corporation (NASDAQ: BGXX) Announces Pricing of $3.5M Private Placement

Bright Green (NASDAQ: BGXX) is one of the few companies selected by the U.S. government to grow, manufacture and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export. The company recently announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 3,684,210 shares of common stock and warrants to purchase up to 3,684,210 shares of common stock, at a purchase price of $0.95 per share and accompanying warrant. Bright Green expects approximately $3.5 million in gross proceeds from the private placement. EF Hutton, division…

ThursdayMay 25, 2023 1:14 pm

CannabisNewsBreaks – Jaxx Cannabis Owner, Veteran and Cannabis Advocate Featured in Recent Episode of The Plant Lady

Female empowerer and owner of Jaxx Cannabis, JM Balbuena, was featured in a recent episode of The Plant Lady podcast. JM joined host Jackie Bryant to discuss her wellness brand and dispensary’s humble beginnings in San Diego county, which wanted to scrub cannabis culture from its image, to the company’s success, which JM attributes much to patience and working for the system instead of against it. During the program, the host and guest “reminisce about the low-key dispensaries scattered around every neighborhood and the elaborate rouses needed as a front to keep them open like under-stocked coffee shops or deserted…

ThursdayMay 25, 2023 12:59 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Plans to Participate in Virtual Investor Events Next Week

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, will be represented at two upcoming investor events. The company announced that members of its executive team will be participating in the Tribe Public Webinar, slated for May 31, 2023, and the Investor Summit, scheduled for June 1, 2023. According to the announcement, InMed CEO Eric A. Adams and BayMedica VP of sales and marketing Jerry Griffin will cohost a presentation for the Tribe Public Webinar. The virtual presentation, titled “Addressing the Increasing Demand for Rare Cannabinoids,” will begin at…

TuesdayMay 23, 2023 3:20 pm

CannabisNewsBreaks – GRN Holding Corporation (GRNF), Marijuana Inc. Complete Merger, Positioning as Frontrunner in the Cannabis Industry

GRN Holding Corporation (OTC: GRNF) today announced successful completion of its merger with Marijuana Inc., solidifying a position as a dominant player in the cannabis industry. The milestone achievement marks a significant step forward in the shared vision of delivering high-quality cannabis products and driving innovation in the market. “We are delighted to announce the successful completion of the merger between GRN Holding Corporation and Marijuana Inc. This strategic consolidation positions us as a frontrunner in the cannabis industry, enabling us to provide exceptional products, expand market reach, and drive sustainable growth,” said GRNF CEO Donald Steinberg. “Together, we are…

TuesdayMay 23, 2023 3:08 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Positive Findings from DehydraTECH-CBD Hypertension Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced additional findings from last year’s human clinical study HYPER-H21-4. The findings demonstrate significant reductions in several pro-inflammatory biomarkers known to be linked to cardiovascular disease (“CVD”) and a host of other conditions. “There is some pre-clinical evidence for the anti-inflammatory actions of CBD, but this is likely the most convincing evidence in humans that I have ever seen,” said Dr. Philip Ainslie, cardiovascular advisor to Lexaria and lead investigator of the HYPER-H21-4 study. “The bigger picture is that inflammation is the key basis of atherosclerosis, and…

News and publishing service for cannabis related companies

Contact us: 303.498.7722

CannabisNewsBreaks